Contact DMCA Privacy

Robuta

https://www.mdpi.com/2077-0383/12/10/3468
Progress and Challenges of Immune Checkpoint Inhibitor-Induced Hypophysitis
Immune checkpoint inhibitors (ICIs) are a new type of antitumor drug which can achieve antitumor goals by blocking the binding of immune checkpoints to their...
immune checkpoint inhibitorprogresschallengesinducedhypophysitis
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1454114/full
Frontiers | Clinical characteristics and biomarkers of severe immune checkpoint inhibitor-related...
BackgroundThe advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment landscape for tumor patients, dramatically improving survival ra...
immune checkpoint inhibitorfrontiersclinicalcharacteristicsbiomarkers
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1512972/full
Frontiers | Effect of immune checkpoint inhibitor time-of-day infusion on survival in advanced...
BackgroundCircadian rhythms in the immune system and anti-tumor responses are underexplored in cancer immunotherapy. Despite the success of immune checkpoint...
immune checkpoint inhibitorfrontierseffecttimeday